Curis Financials
Financial Health Signals
Curis passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Curis generates $0.91 in operating cash flow (-$39.6M OCF vs -$43.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
This page shows Curis (CRIS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Curis generated $10.9M in revenue in fiscal year 2024. This represents an increase of 8.8% from the prior year.
Curis's EBITDA was -$44.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.8% from the prior year.
Curis reported -$43.4M in net income in fiscal year 2024. This represents an increase of 8.5% from the prior year.
Curis earned $-6.88 per diluted share (EPS) in fiscal year 2024. This represents an increase of 23.2% from the prior year.
Curis held $20.0M in cash against $0 in long-term debt as of fiscal year 2024.
Curis had 8M shares outstanding in fiscal year 2024. This represents an increase of 44.0% from the prior year.
Curis's operating margin was -408.3% in fiscal year 2024, reflecting core business profitability. This is up 73.9 percentage points from the prior year.
Curis's net profit margin was -397.8% in fiscal year 2024, showing the share of revenue converted to profit. This is up 75.3 percentage points from the prior year.
Curis invested $38.6M in research and development in fiscal year 2024. This represents a decrease of 2.4% from the prior year.
CRIS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2M+15.5% | $2.7M+15.5% | $2.4M-28.8% | $3.3M+31.4% | $2.5M+22.1% | $2.1M-22.6% | $2.7M-4.8% | $2.8M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $6.4M-13.8% | $7.5M-12.7% | $8.5M-4.8% | $9.0M-12.5% | $10.3M+6.6% | $9.6M-3.5% | $10.0M-4.0% | $10.4M |
| SG&A Expenses | $3.7M+3.6% | $3.5M-11.5% | $4.0M+18.8% | $3.4M-30.0% | $4.8M-2.0% | $4.9M+0.3% | $4.9M+2.4% | $4.8M |
| Operating Income | -$6.9M+16.1% | -$8.3M+18.8% | -$10.2M-12.9% | -$9.0M+28.1% | -$12.5M-0.3% | -$12.5M-2.2% | -$12.2M+1.4% | -$12.4M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$7.7M+10.1% | -$8.6M+19.1% | -$10.6M-10.4% | -$9.6M+18.5% | -$11.8M+0.6% | -$11.9M-1.4% | -$11.7M+3.9% | -$12.2M |
| EPS (Diluted) | $-0.49+27.9% | $-0.68+45.6% | $-1.25-13.6% | $-1.10+45.8% | $-2.03+1.0% | $-2.05-4.1% | $-1.97+7.5% | $-2.13 |
CRIS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.6M-5.4% | $29.2M-25.7% | $39.3M-4.7% | $41.3M-18.1% | $50.4M-18.7% | $62.0M-19.7% | $77.3M-14.1% | $90.0M |
| Current Assets | $13.9M-3.6% | $14.4M-41.9% | $24.8M-6.0% | $26.4M-23.6% | $34.5M-25.1% | $46.1M-24.4% | $60.9M-17.0% | $73.4M |
| Cash & Equivalents | $9.1M-10.7% | $10.1M-50.0% | $20.3M+1.4% | $20.0M+100.1% | $10.0M-66.6% | $30.0M+12.3% | $26.7M+9.0% | $24.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $3.2M+17.8% | $2.8M+18.9% | $2.3M-30.9% | $3.3M+31.5% | $2.5M+18.2% | $2.2M-22.9% | $2.8M-1.9% | $2.8M |
| Goodwill | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M0.0% | $9.0M |
| Total Liabilities | $42.3M-2.1% | $43.2M-5.9% | $45.9M-2.8% | $47.3M-7.5% | $51.1M-2.8% | $52.6M-8.8% | $57.6M-4.6% | $60.4M |
| Current Liabilities | $19.9M+2.8% | $19.4M-3.7% | $20.1M+5.7% | $19.0M-1.8% | $19.4M+71.3% | $11.3M-48.7% | $22.0M+60.6% | $13.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$14.7M-5.0% | -$14.0M-111.7% | -$6.6M-10.2% | -$6.0M-764.3% | -$694K-107.3% | $9.5M-51.9% | $19.7M-33.5% | $29.6M |
| Retained Earnings | -$1.3B-0.6% | -$1.3B-0.7% | -$1.3B-0.9% | -$1.2B-1.6% | -$1.2B-1.0% | -$1.2B-1.0% | -$1.2B-1.0% | -$1.2B |
CRIS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.6M+30.5% | -$8.0M-10.4% | -$7.3M+21.7% | -$9.3M+16.8% | -$11.1M+15.8% | -$13.2M-29.9% | -$10.2M-24.5% | -$8.2M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$10.2M-24.5% | -$8.2M |
| Investing Cash Flow | $0 | $0 | $0+100.0% | -$428K+94.2% | -$7.4M-138.9% | $18.9M+30.3% | $14.5M+7965.0% | $180K |
| Financing Cash Flow | $4.5M+309.9% | -$2.1M-128.3% | $7.5M-14.7% | $8.8M+703.2% | -$1.5M+39.2% | -$2.4M-13.6% | -$2.1M-116.9% | $12.6M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CRIS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -218.0%+82.1pp | -300.1%+126.6pp | -426.8%-157.9pp | -268.9%+222.6pp | -491.4%+106.3pp | -597.8%-145.3pp | -452.5%-15.9pp | -436.6% |
| Net Margin | -243.4%+69.2pp | -312.6%+133.5pp | -446.0%-158.5pp | -287.5%+176.1pp | -463.6%+105.7pp | -569.3%-134.9pp | -434.4%-4.5pp | -430.0% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -28.0%+1.4pp | -29.4%-2.4pp | -27.0%-3.7pp | -23.3%+0.1pp | -23.4%-4.3pp | -19.1%-4.0pp | -15.2%-1.6pp | -13.5% |
| Current Ratio | 0.70-0.0 | 0.74-0.5 | 1.23-0.2 | 1.39-0.4 | 1.78-2.3 | 4.08+1.3 | 2.77-2.6 | 5.36 |
| Debt-to-Equity | -2.88+0.2 | -3.09+3.9 | -6.95+0.9 | -7.88+65.8 | -73.64-79.2 | 5.56+2.6 | 2.93+0.9 | 2.04 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | -377.8%-89.0pp | -288.8% |
Note: Shareholder equity is negative (-$6.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is Curis's annual revenue?
Curis (CRIS) reported $10.9M in total revenue for fiscal year 2024. This represents a 8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Curis's revenue growing?
Curis (CRIS) revenue grew by 8.8% year-over-year, from $10.0M to $10.9M in fiscal year 2024.
Is Curis profitable?
No, Curis (CRIS) reported a net income of -$43.4M in fiscal year 2024, with a net profit margin of -397.8%.
What is Curis's earnings per share (EPS)?
Curis (CRIS) reported diluted earnings per share of $-6.88 for fiscal year 2024. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Curis's EBITDA?
Curis (CRIS) had EBITDA of -$44.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Curis's operating margin?
Curis (CRIS) had an operating margin of -408.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Curis's net profit margin?
Curis (CRIS) had a net profit margin of -397.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Curis's operating cash flow?
Curis (CRIS) generated -$39.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Curis's total assets?
Curis (CRIS) had $41.3M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does Curis spend on research and development?
Curis (CRIS) invested $38.6M in research and development during fiscal year 2024.
How many shares does Curis have outstanding?
Curis (CRIS) had 8M shares outstanding as of fiscal year 2024.
What is Curis's current ratio?
Curis (CRIS) had a current ratio of 1.39 as of fiscal year 2024, which is considered adequate.
What is Curis's debt-to-equity ratio?
Curis (CRIS) had a debt-to-equity ratio of -7.88 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Curis's return on assets (ROA)?
Curis (CRIS) had a return on assets of -105.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Curis's cash runway?
Based on fiscal year 2024 data, Curis (CRIS) had $20.0M in cash against an annual operating cash burn of $39.6M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Curis's debt-to-equity ratio negative or unusual?
Curis (CRIS) has negative shareholder equity of -$6.0M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Curis's Piotroski F-Score?
Curis (CRIS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Curis's earnings high quality?
Curis (CRIS) has an earnings quality ratio of 0.91x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.